Corestreet Logo

G1 Therapeutics Inc (GTHX) Insider Trading

Total insider buys:
  • $18,200,044.00
Total insider sells:
  • $65,822,478.99
Most recent insider trade:
  • March 18, 2024
Most active insider trader:
  • Mark A Velleca
Trader NameDateTitleAmountPriceTypeTotal Value
Dec. 3, 2018SVP3,523$38.54Sell$135,776.42
Nov. 15, 2018Insider3,776$39.75Sell$150,096.00
Nov. 15, 2018CFO5,000$39.92Sell$199,600.00
Nov. 5, 2018SVP3,519$41.53Sell$146,144.07
Nov. 5, 2018Director10,000$41.53Sell$415,300.00
Nov. 5, 2018VP750$41.38Sell$31,035.00
Oct. 15, 2018Insider5,000$41.53Sell$207,650.00
Oct. 8, 2018VP750$44.52Sell$33,390.00
Oct. 4, 2018Director10,000$49.72Sell$497,200.00
Oct. 3, 2018SVP3,519$49.18Sell$173,064.42
Sept. 17, 2018Insider3,776$66.08Sell$249,518.08
Sept. 5, 2018VP750$59.60Sell$44,700.00
Sept. 4, 2018SVP3,519$59.98Sell$211,069.62
Sept. 4, 2018Director10,000$59.95Sell$599,500.00
Aug. 30, 2018Insider10,000$59.60Sell$596,000.00
Aug. 15, 2018Insider5,000$55.88Sell$279,400.00
Aug. 6, 2018Director10,000$50.69Sell$506,900.00
Aug. 6, 2018VP750$50.79Sell$38,092.50
Aug. 3, 2018SVP3,519$50.60Sell$178,061.40
July 16, 2018Insider5,000$42.06Sell$210,300.00
July 5, 2018VP750$45.66Sell$34,245.00
June 15, 2018Insider3,776$44.31Sell$167,314.56
June 5, 2018VP750$38.77Sell$29,077.50
May 30, 2018Major Shareholder800,000$48.00Sell$38,400,000.00
May 23, 2018Major Shareholder37,500$51.11Sell$1,916,625.00
May 15, 2018Insider7,500$46.28Sell$347,100.00
May 7, 2018VP750$45.00Sell$33,750.00
April 16, 2018Insider7,500$36.00Sell$270,000.00
April 5, 2018VP750$37.47Sell$28,102.50
March 15, 2018Insider3,776$38.18Sell$144,167.68
March 5, 2018VP750$26.55Sell$19,912.50
Feb. 15, 2018Insider3,776$20.00Sell$75,520.00
Feb. 5, 2018VP750$22.99Sell$17,242.50
Jan. 16, 2018Insider3,776$22.96Sell$86,696.96
Jan. 5, 2018VP750$19.96Sell$14,970.00
Dec. 18, 2017Insider7,500$20.01Sell$150,075.00
Dec. 15, 2017Major Shareholder200,000$19.75Sell$3,950,000.00
Dec. 1, 2017Major Shareholder133,906$19.75Sell$2,644,643.50
Nov. 20, 2017Major Shareholder200,000$20.01Sell$4,002,000.00
Nov. 13, 2017Director250,000$19.73Buy$4,932,500.00
May 22, 2017Insider400,000$15.00Buy$6,000,000.00
May 22, 2017Major Shareholder133,333$15.00Buy$1,999,995.00
May 22, 2017Director300,000$15.00Buy$4,500,000.00
First«2 of 2»Last

  • Insiders are both buying and selling G1 Therapeutics Inc stock.

  • The insider traders at G1 Therapeutics Inc are: Mark A Velleca, Rajesh Malik, Jennifer K Moses, Seth Rudnick, Terry L Murdock, John E (Jack) Jr. Bailey, Clay Thorp, James S Hanson, Medimmune Ventures, Inc., Andrew Perry, Fredric N Eshelman, John W V Umstead, Mark A. Velleca, Barclay A Phillips, Jay Strum, Ra Capital Healthcare Fund Lp, Glenn P Muir, Cynthia Schwalm, and John Demaree

  • The most active insider trader at G1 Therapeutics Inc is Mark A Velleca with 19 trades.

  • Clay Thorp has sold the most G1 Therapeutics Inc stock with a total value of $78,716,625.00.

  • Fredric N Eshelman has bought the most G1 Therapeutics Inc stock with a total value of $14,365,000.00.

  • The most recent insider trade for G1 Therapeutics Inc was on March 18, 2024.

  • The single biggest insider buy for G1 Therapeutics Inc was from Ra Capital Healthcare Fund Lp with a total value of $6,000,000.00 on May 22, 2017.

  • The single biggest insider sell for G1 Therapeutics Inc was from Clay Thorp with a total value of $38,400,000.00 on May 30, 2018.